Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07336433Not ApplicableNot Yet Recruiting

SMART-IC-Pilot Study

Role: lead

NCT06780696Not Yet Recruiting

SMART Study in Real World

Role: lead

NCT03765307Not ApplicableActive Not Recruiting

Bronchial Ablation for Treatment of Asthma (BATA) Trial

Role: lead

NCT02761811Not ApplicableActive Not Recruiting

Sympathetic Mapping/ Ablation of Renal Nerves Trial

Role: lead

NCT04872114Not ApplicableUnknown

Sympathetic Mapping/ Ablation of Renal Nerves Trial - Hemodialysis

Role: collaborator

All 5 trials loaded